Cambrian Genomics
Latest round
- Series A
Last raised
- Dec 2014
Total raised
- $11M
Investors
- 7
About Cambrian Genomics
Cambrian Genomics Inc.Founded in 2011 and headquartered in San Francisco, US, Cambrian Genomics Inc. specializes in genomics and has undergone strategic pivots to hone its focus on genetic sequencing technologies. The company was founded by Austen Heinz, who has a background in entrepreneurship.Cambrian Genomics specializes in providing advanced genetic sequencing technologies that enhance genomic research. Their proprietary platform utilizes sequencing by synthesis techniques to determine the arrangement of nucleotide bases in DNA, essential for identifying genetic variations linked to diseases.Cambrian Genomics generates revenue through B2B transactions, offering genomic sequencing services or access to their proprietary platform.23 mn to further develop their sequencing technologies and expand their service offerings. They are looking to target new markets in Asia and Europe by 2025, aiming to establish partnerships with more healthcare providers and research institutions.
Who invested in Cambrian Genomics
7 investors across 3 rounds
See all investors in Cambrian Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cambrian Genomics
Who invested in Cambrian Genomics?
Cambrian Genomics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cambrian Genomics raised?
Cambrian Genomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cambrian Genomics last raise money?
Cambrian Genomics's most recent round on record is a Series A, in Dec 2014.
What does Cambrian Genomics do?
Cambrian Genomics is a healthcare it company.
Where is Cambrian Genomics headquartered?
Cambrian Genomics is headquartered in San Francisco, US.
Which VCs invest in companies like Cambrian Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Cambrian Genomics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Cambrian Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.